NASDAQ: TOI
Oncology Institute Inc Stock Ownership - Who owns Oncology Institute?

Insider buying vs selling

Have Oncology Institute Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Robert Ross CarterChief Financial Officer2025-01-06258$0.34
$86.43Sell
Jeremy CastleChief Operating Officer2024-12-031,130$0.16
$180.80Sell
Brad HivelyDirector2024-12-0250,000$0.15
$7.50kBuy
Brad HivelyDirector2024-11-26250,000$0.17
$42.50kBuy
Robert Ross CarterChief Financial Officer2024-11-20235$0.14
$31.96Sell
Yale PodnosChief Medical Officer2024-11-201,026$0.14
$139.54Sell
Yale PodnosChief Medical Officer2024-11-20267$0.14
$36.05Sell
Yale PodnosChief Medical Officer2024-11-201,709$0.14
$232.42Sell
Daniel VirnichChief Executive Officer2024-11-204,977$0.14
$676.87Sell
Daniel VirnichChief Executive Officer2024-11-204,750$0.14
$646.00Sell

1 of 2

TOI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TOI insiders and whales buy or sell their stock.

TOI Shareholders

What type of owners hold Oncology Institute Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
M33 Growth I LP20.19%15,256,383$5.64MInsider
Ravi Yang Sarin16.42%12,404,740$4.59MInsider
Fmr LLC6.29%4,749,900$1.76MInstitution
Deerfield Management Company LP Series C4.45%3,360,052$1.24MInstitution
James E. Flynn4.36%3,296,107$1.22MInsider
Tiff Advisory Services LLC3.48%2,632,885$974.17kInstitution
Cincinnati Insurance Co2.69%2,034,045$752.60kInstitution
Kent Lake Pr LLC2.65%2,000,000$740.00kInstitution
Vanguard Group Inc2.36%1,783,454$659.88kInstitution
Balyasny Asset Management LP2.28%1,725,562$638.46kInstitution

1 of 3

TOI vs Medical Care Facility Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TOI27.03%46.63%Net BuyingNet Buying
CCM0.00%0.00%
AMS16.51%83.49%
SYRA7.86%7.84%Net Buying
RHE0.20%99.80%

Oncology Institute Stock Ownership FAQ

Who owns Oncology Institute?

Oncology Institute (NASDAQ: TOI) is owned by 27.03% institutional shareholders, 46.63% Oncology Institute insiders, and 26.33% retail investors. M33 Growth I LP is the largest individual Oncology Institute shareholder, owning 15.26M shares representing 20.19% of the company. M33 Growth I LP's Oncology Institute shares are currently valued at $6.10M.

If you're new to stock investing, here's how to buy Oncology Institute stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.